Anderson DR, O'Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty. Ann Intern Med. 1993 Dec 1;119(11):1105-12.
Chan KB, Man-Son-Hing M, Molnar FJ, Laupacis A How well is the clinical importance of study results reported? An assessment of randomized controlled trials. CMAJ. 2001 Oct 30;165(9):1197-202.
Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med. 2001 Sep 18;135(6):393-400.
Landefeld CS, Beyth RJ Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993 Sep;95(3):315-28. Review.
Landefeld CS, Goldman L Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989 Aug;87(2):144-52.
Landefeld CS, Rosenblatt MW, Goldman L Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions. Am J Med. 1989 Aug;87(2):153-9.
Libby EN, Garcia DA A survey of oral vitamin K use by anticoagulation clinics. Arch Intern Med. 2002 Sep 9;162(16):1893-6.
Odén A, Fahlén M Oral anticoagulation and risk of death: a medical record linkage study. BMJ. 2002 Nov 9;325(7372):1073-5.
Raj G, Kumar R, McKinney WP Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med. 1999 Dec 13-27;159(22):2721-4. Erratum in: Arch Intern Med 2000 Apr 10;160(7):986.
Warkentin TE, Crowther MA Reversing anticoagulants both old and new. Can J Anaesth. 2002 Jun-Jul;49(6):S11-25. Review.
Watson HG, Baglin T, Laidlaw SL, Makris M, Preston FE A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin. Br J Haematol. 2001 Oct;115(1):145-9.
Wilson SE, Watson HG, Crowther MA Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review. CMAJ. 2004 Mar 2;170(5):821-4. Review.
A Multicentre, Multinational Study of Oral Vitamin K for the Treatment of Warfarin Associated Coagulopathy
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
